undefined
EUTM file information

018902202

Syngene SynTACS

July 16, 2023

Trademark Summary

The trademark Syngene SynTACS was filed by Syngene International Limited, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on September 28, 2023, and received one opposition filed on December 20, 2023 by SYNGENTA PARTICIPATIONS AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 20, 2023

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Bio-technological products including, enzymes, protein carbohydrates, lipids, and nucleic acids, DNA products, immunological re-agents, and fine chemicals including organic intermediates
    2. Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions
    3. Assays for research purposes
    4. Biomedical compounds, namely, peptide substrates used in analysing and detecting certain toxins for laboratory, research, clinical or medical laboratory use
    5. Chemical polymers
    6. Chemicals for use in biotechnological product development
    7. Chemicals, namely, chitosan
    8. Chitosan for industrial purposes
    9. Aldehydes
    10. Chromatography chemicals
    11. Cells for scientific, laboratory or medical research
    12. Reagents for use in the development of hybridoma antibodies [other than for medical or veterinary purposes]
    13. Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes
    14. Nucleotides for scientific and research use
    15. Protein arrays and nucleotide arrays for scientific and medical research
    16. Peptides for industrial purposes
    17. Proteins for use in recombinant DNA technology [other than for medical use]
    18. Specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods
    19. Reference standards [chemicals] for use in science and industry
    20. Isotopes for industrial purposes
    21. Biochemicals for in vitro and in vivo scientific use
    22. Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
    23. Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
    24. None of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes.
  • The mark was filed in class 5 with following description of goods:
    1. Bio-logical and bio-technological products pertaining to pharmaceutical and medical industries and formulations thereof
    2. Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
    3. Antibodies
    4. Synthetic peptides for pharmaceutical purposes
    5. Aldehydes for pharmaceutical purposes
    6. Imaging agents for magnetic resonance imaging (MRI)
    7. Nucleic acid sequences and chemical reagents for medical and veterinary purposes
    8. Pharmaceutical preparations and substances for use in oncology
    9. Biological tissue grafts
    10. Vascular grafts [living tissue]
    11. Biopharmaceuticals for the treatment of cancer
    12. Yeast and yeast extracts for medical, veterinary or pharmaceutical purposes
    13. Proteins for use in recombinant DNA technology for medical purposes
    14. Regulatory proteins for medical use
    15. Medicines for veterinary purposes
    16. Isotopes for medical purposes
    17. Biological preparations for medical purposes
    18. Chemical preparations for use in DNA analysis [medical]
    19. Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
    20. None of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes.
  • The mark was filed in class 10 with following description of goods:
    1. Surgical, medical, dental and veterinary instruments and apparatus
    2. Artificial limbs, eyes and teeth
    3. None of the aforesaid goods relating to gel imaging and gel analysis applications.
  • The mark was filed in class 16 with following description of goods:
    1. Paper and paper articles
    2. Paper and cardboard, office machines and labels
    3. Printed matter, newspaper and periodicals books
    4. Book-binding materials
    5. Photographs stationery
    6. Adhesive materials (stationery)
    7. Artists’ materials
    8. Paint brushes typewrite and office requisites (other than furniture)
    9. Instructional and teaching materials (other than apparatus)
    10. Printers type and printing clichés (stereotype)
    11. Directories and journals, printed training materials in the field of clinical study, medical writing & pharmacovigilance services
    12. None of the aforesaid goods relating to gel imaging and gel analysis applications
    13. None of the aforesaid goods used for packaging of agrochemical products and seeds.
  • The mark was filed in class 35 with following description of goods:
    1. Business advisory services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services
    2. Consulting services in the field of medical practice management for others
    3. Business consulting and management in the field of clinical trials, namely, providing information management services
    4. Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
    5. Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
    6. Business management consulting services in the field of pharmaceuticals drug development
    7. None of the aforesaid services relating to gel imaging and gel analysis applications.
  • The mark was filed in class 39 with Storage of human cells.
  • The mark was filed in class 40 with following description of goods:
    1. Polymerization
    2. Custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, medicines, drugs by pharmaceutical compounders
    3. Contract manufacturing in the field of pharmaceuticals and drug development.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific research and custom synthesis
    2. Scientific and clinical research
    3. Scientific research and development
    4. Custom design and development of chemical reagents and biochemical assays
    5. Laboratory testing
    6. Laboratory testing services
    7. Testing of pharmaceuticals
    8. Chemical engineering
    9. Behavioural analysis of chemicals
    10. Drug discovery services
    11. Pharmaceutical drug development services
    12. Pharmaceutical products development
    13. Development of pharmaceutical preparations and medicines
    14. Scientific study and research in the field of reproduction, husbandry, and general health of animal
    15. Biotechnology research for determining the neuronal survival of molecules in animal models
    16. Research and development services in the field of antibodies, antibody technology
    17. Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications
    18. Toxicology services
    19. Toxicity analysis
    20. Toxicity testing for research purposes
    21. Clinical trials (conducting)
    22. Conducting clinical trials for others [scientific research]
    23. Conducting clinical trials for pharmaceutical products
    24. Providing medical and scientific research information in the field of clinical trials
    25. Conducting early evaluations in the field of new pharmaceuticals
    26. DNA analysis services for scientific research purposes
    27. Laboratory research in the field of gene expression
    28. Blood analysis services for scientific research purposes
    29. Analysis of human tissues for medical research
    30. Scientific services relating to the isolation and cultivation of human tissues and cells
    31. Preparation of reports relating to scientific and technical research
    32. Analysis in the field of molecular biology
    33. Contract research services relating to molecular sciences
    34. Biological cloning services
    35. Structural and functional analysis of genomes
    36. Laboratory services
    37. Services of a chemical and/or biological laboratory
    38. Laboratory research services relating to pharmaceuticals
    39. Research and development and consultation related thereto in the field of antibodies, antibody technology
    40. Research and development and consultation related thereto in the field of chemistry, bioinformatics, biomedical, biologics, biotechnology, bio therapeutics, biology, biochemical
    41. Research and development and consultation related thereto in the field of cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms
    42. Research and development and consultation related thereto in the field of nutrition, ophthalmic, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, solid state characterization
    43. Toxicokinetic
    44. Toxicology
    45. Scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibody, API, biomolecules, cell bank characterization, chiral, chromosome aberration
    46. Scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene
    47. Scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nano particle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines
    48. None of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry.
  • The mark was filed in class 44 with following description of goods:
    1. Medical diagnostic testing, monitoring and reporting services
    2. Preparation of reports relating to medical matters
    3. Services for the testing of urine
    4. Pathology services.